Skip to main content
SpringerLink
Log in

PPM1D overexpression predicts poor prognosis in non-small cell lung cancer

  • Research Article
  • Published:
Tumor Biology

Abstract

It has been reported that protein phosphatase, Mg2+/Mn2+ dependent, 1D (PPM1D) plays an important role in cancer tumorigenesis. However, the clinical and functional significance of PPM1D expression has not been characterized previously in non-small cell lung cancer (NSCLC). The purpose of this study was to assess PPM1D expression and to explore its contribution to NSCLC. We examined PPM1D messenger RNA (mRNA) expression in 53 NSCLC tissues and matched adjacent noncancerous tissues by quantitative reverse transcription PCR (qRT-PCR). Furthermore, the PPM1D protein expression was analyzed by immunohistochemistry in 157 NSCLC samples. The relationship between PPM1D expression and clinicopathological features was analyzed by appropriate statistics. Kaplan-Meier analysis and Cox proportional hazards regression models were used to investigate the correlation between PPM1D expression and prognosis of NSCLC patients. The relative mRNA expression of PPM1D was significantly elevated in NSCLC tissues as compared with adjacent noncancerous tissues (P < 0.001). The high expression of PPM1D in NSCLC tissues was significantly correlated with tumor grade (P = 0.006), tumor size (P = 0.017), clinical stage (P = 0.001), and lymph node metastases (P = 0.002). Kaplan-Meier survival analysis revealed that high PPM1D expression correlated with poor prognosis of NSCLC patients (P < 0.001). Multivariate analysis showed that PPM1D expression was an independent prognostic marker for overall survival of NSCLC patients. In conclusion, PPM1D plays an important role in the progression of NSCLC. PPM1D may potentially be used as an independent biomarker for the prognostic evaluation of NSCLC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–50. doi:10.1200/JCO.2005.05.2308.

    Article  PubMed  Google Scholar 

  2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–49. doi:10.3322/caac.20006.

    Article  PubMed  Google Scholar 

  3. Pisters KM, Evans WK, Azzoli CG, Kris MG, Smith CA, et al. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. J Clin Oncol. 2007;25(34):5506–18. doi:10.1200/JCO.2007.14.1226.

    Article  PubMed  Google Scholar 

  4. Lu G, Wang Y. Functional diversity of mammalian type 2C protein phosphatase isoforms: new tales from an old family. Clin Exp Pharmacol Physiol. 2008;35:107–12. doi:10.1111/j.1440-1681.2007.04843.x.

    Article  CAS  PubMed  Google Scholar 

  5. Bulavin DV, Demidov ON, Saito S, Kauraniemi P, Phillips C, Amundson SA, et al. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat Genet. 2002;31:210–5. doi:10.1038/ng894.

    Article  CAS  PubMed  Google Scholar 

  6. Li J, Yang Y, Peng Y, Austin RJ, van Eyndhoven WG, Nguyen KC, et al. Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23. Nat Genet. 2002;31:133–4. doi:10.1038/ng888.

    Article  CAS  PubMed  Google Scholar 

  7. Lu X, Nguyen TA, Appella E, Donehower LA. Homeostatic regulation of base excision repair by a p53-induced phosphatase: linking stress response pathways with DNA repair proteins. Cell Cycle. 2004;3:1363–6.

    Article  CAS  PubMed  Google Scholar 

  8. Castellino RC, De Bortoli M, Lu X, Moon SH, Nguyen TA, Shepard MA, et al. Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D. J Neurooncol. 2008;86:245–56. doi:10.1007/s11060-007-9470-8.

    Article  CAS  PubMed  Google Scholar 

  9. Saito-Ohara F, Imoto I, Inoue J, Hosoi H, Nakagawara A, Sugimoto T, et al. PPM1D is a potential target for 17q gain in neuroblastoma. Cancer Res. 2003;63:1876–83.

    CAS  PubMed  Google Scholar 

  10. Loukopoulos P, Shibata T, Katoh H, Kokubu A, Sakamoto M, Yamazaki K, et al. Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome. Cancer Sci. 2007;98:392–400. doi:10.1111/j.1349-7006.2007.00395.x.

    Article  CAS  PubMed  Google Scholar 

  11. Tan DS, Lambros MB, Rayter S, Natrajan R, Vatcheva R, Gao Q, et al. PPM1D is a potential therapeutic target in ovarian clear cell carcinomas. Clin Cancer Res. 2009;15:2269–80. doi:10.1158/1078-0432.CCR-08-2403.

    Article  CAS  PubMed  Google Scholar 

  12. Yu E, Ahn YS, Jang SJ, Kim MJ, Yoon HS, Gong G, et al. Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers. Breast Cancer Res Treat. 2007;101:269–78.

    Article  CAS  PubMed  Google Scholar 

  13. Rauta J, Alarmo EL, Kauraniemi P, Karhu R, Kuukasjärvi T, Kallioniemi A. The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours. Breast Cancer Res Treat. 2006;95:257–63.

    Article  CAS  PubMed  Google Scholar 

  14. Satoh N, Maniwa Y, Bermudez VP, Nishimura K, Nishio W, Yoshimura M, et al. Oncogenic phosphatase Wip1 is a novel prognostic marker for lung adenocarcinoma patient survival. Cancer Sci. 2011;102:1101–6. doi:10.1111/j.1349-7006.2011.01898.x.

    Article  CAS  PubMed  Google Scholar 

  15. Zhang C, Chen Y, Wang M, Chen X, Li Y, Song E, et al. PPM1D silencing by RNA interference inhibits the proliferation of lung cancer cells. World J Surg Oncol. 2014;12:258. doi:10.1186/1477-7819-12-258.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Tu L, Liu Z, He X, He Y, Yang H, Jiang Q, et al. Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma. Mol Cancer. 2010;9:78. doi:10.1186/1476-4598-9-78.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Liu Z, Li L, Yang Z, Luo W, Li X, Yang H, et al. Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma. BMC Cancer. 2010;10:270. doi:10.1186/1471-2407-10-270.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Zhong X, Li M, Nie B, Wu F, Zhang L, Wang E, et al. Overexpressions of RACK1 and CD147 associated with poor prognosis in stage T1 pulmonary adenocarcinoma. Ann Surg Oncol. 2013;20:1044–52. doi:10.1245/s10434-012-2377-4.

    Article  PubMed  Google Scholar 

  19. Ganem NJ, Godinho SA, Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature. 2009;460:278–82. doi:10.1038/nature08136.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Niu Y, Liu T, Tse GM, Sun B, Niu R, Li HM, et al. Increased expression of centrosomal alpha, gamma-tubulin in atypical ductal hyperplasia and carcinoma of the breast. Cancer Sci. 2009;100:580–7. doi:10.1111/j.1349-7006.2008.01075.x.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Respiratory Department, Yantai Hospital of Traditional Chinese Medicine, No. 39, Xingfu Road, Zhifu District, Yantai, 264002, China

    Hua Yang & Ping Li

  2. Neurology Department, Yantai Yuhuangding Hospital Affiliated to Qingdao University, No. 20, Yuhuangding East Road, Zhifu District, Yantai, 264000, China

    Xiao-Yu Gao

  3. Respiratory Department, Yantai Yuhuangding Hospital Affiliated to Qingdao University, No. 20, Yuhuangding East Road, Zhifu District, Yantai, 264000, China

    Ting-Shu Jiang

Authors
  1. Hua Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiao-Yu Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ping Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ting-Shu Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ting-Shu Jiang.

Additional information

Hua Yang, Xiao-Yu Gao, and Ping Li contributed equally to this paper.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, H., Gao, XY., Li, P. et al. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer. Tumor Biol. 36, 2179–2184 (2015). https://doi.org/10.1007/s13277-014-2828-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2828-6

Keywords

Search

Navigation